All Articles
Browse the full archive, newest first.
Kelonia Therapeutics Transforms from Struggles to a $3 Billion Valuation
The biotech sector sees notable developments as Kelonia Therapeutics rebounds significantly, while BioAge focuses on inflammation and other industry updates emerge.
Editorial Staff Apr 21
Roblox Faces Decline in Q1 Amid Investor Concerns
Roblox's performance in the first quarter has reportedly declined, as investors express growing concerns about the company's outlook.
Editorial Staff Apr 21
Carvana Struggles with Rising Costs in First Quarter
Carvana's first quarter results are significantly affected by rising costs, presenting challenges for the company as it navigates financial pressures.
Editorial Staff Apr 21
Axon Enterprise Experiences Valuation Compression Despite Robust Performance
Axon Enterprise has reported strong performance; however, its valuation multiples have seen a decline, raising questions about market perceptions.
Editorial Staff Apr 21
El Niño Influence: 2026 Poised to be One of the Hottest Years on Record
The early months of 2026 have already recorded significant warmth, indicating a potential for the year to rank as the second warmest in history, driven by a strong El Niño.
Editorial Staff Apr 21